Case Control Study
Copyright ©The Author(s) 2024.
World J Hepatol. Nov 27, 2024; 16(11): 1255-1264
Published online Nov 27, 2024. doi: 10.4254/wjh.v16.i11.1255
Figure 4
Figure 4 Comparison of patients stratified based on an optimal tissue plasminogen activator-inhibitor complex cutoff of 11. 9 ng/mL. A: Acute Physiology and Chronic Health Evaluation II score; B: Lactate levels; C: Kaplan-Meier survival curves. APACHE II: Acute Physiology and Chronic Health Evaluation II; t-PAIC: Tissue plasminogen activator-inhibitor complex; Lac: Lactate; CI: Confidence interval.